Elevating feline care: Boehringer Ingelheim launches first Catvocacy forum nationwide

Boehringer Ingelheim launched the first-ever Catvocacy Forum for the company, uniting veterinarians to elevate cat care nationwide. The forum aims to raise the standards of feline care in the Philippines, empowering vets to provide compassionate, quality care.

48.3% of Filipino households own cats with a population of over 2.74 million, highlighting the growing need for veterinarians trained in feline care. Cats often conceal pain, hide illness, and react strongly to stress, making specialized veterinary care essential for early detection, treatment, and prevention.

Pets Date Night celebrates the Next-Level Bond between families and their pets

Pets Date Night, Boehringer Ingelheim’s signature event, celebrates the special bond between pets and their families and highlights the importance of preventive care in keeping pets healthy year-round.

Now in its fifth year, the celebration showcases the joy pets bring to Filipino households while reinforcing responsible pet ownership and preventive pet healthcare. This year’s event offered families more ways to learn and connect, featuring educational talks, carnival games, free treats, a pet fashion show, veterinary check-ups, interactive activities, lively performances, and a captivating light show.

GPCCI RTD Highlights Urgency for Integrated Cardio-Renal-Metabolic Care in the PH

The German-Philippine Chamber of Commerce and Industry (GPCCI), in partnership with the German Embassy Manila and Boehringer Ingelheim Philippines, convened a multi-stakeholder roundtable discussion to address the pressing issue of cardio-renal-metabolic (CRM) health and explore strategies for more integrated and patient-centered care.

The roundtable brought together leaders and experts from medical associations, patient advocacy groups, academic institutions, and the pharmaceutical industry. Discussions focused on aligning efforts across sectors and government agencies to respond to the growing incidence of interconnected cardiovascular, renal, and metabolic conditions.

“Addressing CRM conditions is not only about clinical treatment. It is about equity, education, and empathy,” said Dr. Cherry Sevilla-Arenas, from the Philippine Heart Center on her keynote address. “Despite growing awareness, many patients continue to fall through the cracks due to uneven access and fragmented systems of care. If we want to move toward meaningful health outcomes, we must align our efforts—across government, industry, and communities—to prevent care fragmentation and ensure no Filipino is left behind.”

Angels Initiative, World Stroke Organization, and Stroke Society of the Philippines lead Stroke CARE Meeting to elevate stroke care and build a stroke-ready Philippines

The Stroke CARE (Coalition for Acute Stroke Response and Excellence) Meeting brings together global and local leaders from the World Stroke Organization (WSO), Stroke Society of the Philippines (SSP), and Angels Initiative, Boehringer Ingelheim’s global healthcare program, driving excellence in stroke response and care nationwide. Regional stroke champions from Luzon, Visayas, and Mindanao engaged in the discussions to address the growing burden of stroke in the Philippines and bridge global standards with local solutions for better stroke care. Stroke remains a major public health concern in the Philippines, as the third leading cause of death and a major cause of long-term disability, with 34,464 fatalities from January to August 2024. WSO President Prof. Jeyaraj Pandian reaffirmed the organization’s support for the Philippines, highlighting progress through the WSO Angels Certification Program and emphasizing the need for multisectoral collaboration, community awareness, and capacity-building across all levels of care. Key priorities discussed include the development of a unified national stroke strategy, improved access to timely treatment, adoption of data-driven tools like the Registry of Stroke Care Quality (RES-Q), and expanded training for frontline health workers. The Angels Initiative remains committed to advancing stroke care in the Philippines through strategic partnerships, continuous capacity-building, and a shared vision of a stroke-ready nation.

Elevating Stroke Care: Angels Initiative, SSP Empower Nurses Nationwide Through Stroke Nurse Masterclass

Angels Initiative, Boehringer Ingelheim’s global healthcare advocacy program, is expanding its Stroke Nurse Masterclass nationwide to empower more nurses and elevate stroke care standards. In partnership with the Stroke Society of the Philippines (SSP) as the certifying body, the Stroke Nurse Masterclass 2025 officially launches at New World Hotel, Makati, with a mission to strengthen stroke care capabilities and drive better health outcomes for stroke patients. The program has recently received official endorsement from the World Stroke Organization, recognizing its excellence in stroke education and its meaningful impact in advancing stroke care across the Philippines, in support of WSO’s global mission.

Boehringer Ingelheim receives Philippine Society of Nephrology Presidential Service Award for Kidney Disease Management for Primary Care Physicians

In photo, from left to right: Pelagio L. Emmanuel Jr., MD, Immediate Past President of the Philippine Society of Nephrology; Ricky Solitaria, Senior Product Manager at Boehringer Ingelheim (Philippines), Inc.; Seunghun Lee, Head of Marketing at Boehringer Ingelheim (Philippines), Inc.; and Ricardo A. Francisco Jr., MD, President of the Philippine Society of Nephrology. Boehringer Ingelheim (Philippines), Inc. received the prestigious Presidential Service Award from the Philippine Society of Nephrology in recognition of its commitment to empowering primary care physicians through the Kidney Disease Management for Primary Care Physicians (KDM4PCP) program, equipping them with the knowledge and tools to diagnose, manage, and treat chronic kidney disease (CKD) in the Philippines.

The secret link between hypertension and chronic kidney disease

A patient gets their blood pressure checked during the Get CheCKD event in Ayala Malls Manila Bay, highlighting the importance of early detection and regular monitoring in managing hypertension and preventing chronic kidney disease (CKD). 

A patient gets their blood pressure checked during the Get CheCKD event in Ayala Malls Manila Bay, highlighting the importance of early detection and regular monitoring in managing hypertension and preventing chronic kidney disease (CKD).

Boehringer Ingelheim launches its first-in-class broad-spectrum topical parasite treatment for cats

NexGard® COMBO for cats is a one-and-done, easy-to-use formula with the eprinomectin, praziquantel and next-generation active antiparasitic ingredient: esafoxolaner, which has been specially formulated for cats.

Boehringer Ingelheim, a global leader in animal health, has launched the parasite treatment, NexGard® COMBO for cats. With nearly 20 years of expertise in preventing parasites such as fleas, ticks, Lyme disease and more in dogs, NexGard® now adds a feline-specific product to the NexGard® family. The new treatment is designed to safeguard cats from a wider range of parasites than any other product on the market, covering both external parasites and internal parasites such as fleas, ticks, ear mites, face mange, hookworm, roundworm, vesical worm, lungworm, heartworm prevention, as well as tapeworm infections that affect their health and quality of life. 

Boehringer Ingelheim Philippines is awarded Top Employer for the 5th year in a row

Boehringer Ingelheim is one of 15 global Top Employers worldwide

Achieved Global Recognition and Top Employer Certification in 29 countries From Top Employers Institute® 

Outstanding employer benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition 

Boehringer Ingelheim (Philippines) Inc. is awarded Top Employer for the 5th year in a row.

Boehringer Ingelheim progresses toward sustainability goals through key initiatives across ASEAN, South Korea, Australia, and New Zealand

Strengthening network of stroke-ready hospitals and stroke centers to serve more than 300,000 patients including in the Philippines

Partnering with Global Alliance for Rabies Control (GARC) and community partners to vaccinate 12,000 dogs and cats across the Philippines, Indonesia, Malaysia, and Vietnam in 2022

Empowering employees and social entrepreneurs to pilot and scale accessible health solutions through its signature ‘Making More Health’ flagship initiative

Committing to carbon neutrality in company operations by 2030 (Scope 1 and 2), reducing operational waste, and eliminating single-use plastic

Boehringer Ingelheim is strengthening its commitment to positively impact people, animals, communities, and the planet through key sustainability initiatives in the Philippines and across ASEAN, South Korea, Australia, and New Zealand (ASKAN). 

Under the ‘Sustainable Development – For Generations’ framework, Boehringer Ingelheim has globally pledged EUR 250 million to combat infectious diseases in humans and animals, expanding healthcare access for non-communicable diseases for 50 million people in vulnerable communities, including in the ASKAN area, and invest EUR 35 billion in health innovation to tackle non-communicable diseases. In addition to improving access to healthcare, Boehringer Ingelheim is committed to carbon neutrality in company operations by 2030 (Scope 1 and 2) and is taking steps to contribute to food security and safety, building a sustainable and healthy future for all.